Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 16 | 2023 | 668 | 2.760 |
Why?
|
| DNA Methylation | 5 | 2024 | 153 | 2.080 |
Why?
|
| Fetal Blood | 3 | 2024 | 39 | 1.170 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 147 | 1.130 |
Why?
|
| Placenta | 6 | 2023 | 78 | 1.130 |
Why?
|
| Weight Loss | 4 | 2022 | 81 | 1.060 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2023 | 123 | 1.050 |
Why?
|
| Diet, High-Fat | 4 | 2014 | 137 | 0.940 |
Why?
|
| Adiposity | 3 | 2024 | 94 | 0.900 |
Why?
|
| Behavior Therapy | 2 | 2021 | 29 | 0.880 |
Why?
|
| Microbiota | 2 | 2023 | 95 | 0.860 |
Why?
|
| Pregnancy | 13 | 2024 | 1191 | 0.840 |
Why?
|
| Liver | 9 | 2014 | 441 | 0.830 |
Why?
|
| Preconception Care | 2 | 2021 | 17 | 0.770 |
Why?
|
| Weight Reduction Programs | 1 | 2021 | 9 | 0.710 |
Why?
|
| Dietary Supplements | 2 | 2021 | 253 | 0.650 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 367 | 0.620 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 8 | 0.600 |
Why?
|
| Female | 23 | 2024 | 15191 | 0.580 |
Why?
|
| Micronutrients | 1 | 2018 | 48 | 0.570 |
Why?
|
| Weaning | 2 | 2014 | 18 | 0.480 |
Why?
|
| Mitochondrial Dynamics | 1 | 2014 | 12 | 0.460 |
Why?
|
| Adult | 8 | 2024 | 7765 | 0.450 |
Why?
|
| Infant, Newborn | 5 | 2024 | 890 | 0.440 |
Why?
|
| Male | 19 | 2024 | 13510 | 0.430 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 544 | 0.420 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 16 | 0.420 |
Why?
|
| Rats | 14 | 2014 | 1568 | 0.420 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 76 | 0.420 |
Why?
|
| Genome | 1 | 2013 | 57 | 0.410 |
Why?
|
| Physical Conditioning, Animal | 5 | 2012 | 38 | 0.410 |
Why?
|
| Fatty Liver | 5 | 2011 | 58 | 0.370 |
Why?
|
| Sirtuin 3 | 1 | 2011 | 18 | 0.370 |
Why?
|
| Humans | 17 | 2024 | 28167 | 0.360 |
Why?
|
| Diet | 2 | 2023 | 232 | 0.360 |
Why?
|
| Infant | 2 | 2024 | 1014 | 0.350 |
Why?
|
| Child, Preschool | 2 | 2024 | 1149 | 0.350 |
Why?
|
| Insulin | 5 | 2018 | 315 | 0.350 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 110 | 0.330 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 3 | 2018 | 64 | 0.330 |
Why?
|
| Biomarkers | 3 | 2024 | 763 | 0.330 |
Why?
|
| Muscle, Skeletal | 5 | 2014 | 634 | 0.330 |
Why?
|
| Animals | 19 | 2023 | 10416 | 0.300 |
Why?
|
| Transcription Factors | 4 | 2024 | 522 | 0.290 |
Why?
|
| Child | 2 | 2024 | 2253 | 0.290 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 633 | 0.280 |
Why?
|
| Mitochondria, Muscle | 4 | 2013 | 43 | 0.270 |
Why?
|
| Epigenomics | 2 | 2024 | 29 | 0.260 |
Why?
|
| Eating | 4 | 2022 | 70 | 0.250 |
Why?
|
| Transcriptome | 4 | 2015 | 214 | 0.250 |
Why?
|
| Energy Metabolism | 4 | 2013 | 198 | 0.250 |
Why?
|
| Placentation | 2 | 2015 | 3 | 0.240 |
Why?
|
| Adolescent | 2 | 2024 | 3128 | 0.240 |
Why?
|
| Exercise | 2 | 2023 | 482 | 0.230 |
Why?
|
| CpG Islands | 1 | 2024 | 27 | 0.230 |
Why?
|
| Middle Aged | 5 | 2023 | 7164 | 0.220 |
Why?
|
| Mothers | 2 | 2023 | 122 | 0.220 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 111 | 0.220 |
Why?
|
| Mitochondria, Liver | 5 | 2013 | 12 | 0.220 |
Why?
|
| Fatty Acids | 6 | 2013 | 206 | 0.220 |
Why?
|
| Young Adult | 3 | 2021 | 2738 | 0.220 |
Why?
|
| Adipose Tissue | 5 | 2013 | 184 | 0.210 |
Why?
|
| Pediatrics | 1 | 2024 | 92 | 0.210 |
Why?
|
| Calorimetry, Indirect | 2 | 2014 | 14 | 0.210 |
Why?
|
| Lipid Metabolism | 3 | 2013 | 133 | 0.200 |
Why?
|
| Insulin Resistance | 4 | 2012 | 176 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2023 | 1433 | 0.180 |
Why?
|
| Fluorocarbons | 1 | 2020 | 6 | 0.180 |
Why?
|
| Proteomics | 1 | 2022 | 181 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2022 | 436 | 0.170 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 35 | 0.170 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 82 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2020 | 48 | 0.170 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2020 | 2 | 0.170 |
Why?
|
| Organic Chemicals | 1 | 2020 | 14 | 0.170 |
Why?
|
| Motor Activity | 2 | 2011 | 147 | 0.160 |
Why?
|
| RNA, Messenger | 5 | 2014 | 658 | 0.160 |
Why?
|
| Food | 1 | 2020 | 33 | 0.160 |
Why?
|
| Lipids | 1 | 2021 | 208 | 0.160 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 3 | 2014 | 16 | 0.160 |
Why?
|
| Metabolome | 1 | 2020 | 68 | 0.150 |
Why?
|
| Guatemala | 1 | 2018 | 30 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2021 | 301 | 0.150 |
Why?
|
| Adiponectin | 1 | 2018 | 29 | 0.150 |
Why?
|
| Trophoblasts | 2 | 2015 | 14 | 0.150 |
Why?
|
| Leptin | 1 | 2018 | 67 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2018 | 198 | 0.140 |
Why?
|
| Gestational Age | 1 | 2018 | 146 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2018 | 78 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 91 | 0.130 |
Why?
|
| Histones | 2 | 2015 | 93 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2018 | 398 | 0.130 |
Why?
|
| Caloric Restriction | 2 | 2021 | 73 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 327 | 0.130 |
Why?
|
| Lipogenesis | 2 | 2013 | 29 | 0.130 |
Why?
|
| Oxidation-Reduction | 7 | 2011 | 363 | 0.130 |
Why?
|
| Health Promotion | 1 | 2018 | 176 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 969 | 0.120 |
Why?
|
| Metalloproteases | 1 | 2014 | 7 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 19 | 0.110 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2014 | 20 | 0.110 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 28 | 0.110 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 36 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 72 | 0.110 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 9 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2014 | 180 | 0.110 |
Why?
|
| Biological Clocks | 1 | 2014 | 7 | 0.110 |
Why?
|
| Glucose | 2 | 2012 | 203 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 122 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2014 | 33 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 41 | 0.110 |
Why?
|
| Rats, Inbred OLETF | 5 | 2012 | 5 | 0.110 |
Why?
|
| Lysine | 1 | 2014 | 75 | 0.110 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2013 | 9 | 0.100 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 13 | 0.100 |
Why?
|
| Simvastatin | 1 | 2013 | 24 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 69 | 0.100 |
Why?
|
| Time Factors | 2 | 2014 | 1593 | 0.100 |
Why?
|
| Palmitic Acid | 2 | 2010 | 11 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 345 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2383 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2013 | 172 | 0.090 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 6 | 0.090 |
Why?
|
| Vasodilation | 1 | 2012 | 114 | 0.090 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 22 | 0.090 |
Why?
|
| Blastocyst | 1 | 2011 | 5 | 0.090 |
Why?
|
| Menopause | 1 | 2011 | 30 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2011 | 53 | 0.090 |
Why?
|
| Uterus | 1 | 2011 | 31 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 68 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 465 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 133 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 123 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2014 | 485 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 59 | 0.080 |
Why?
|
| Metabolomics | 2 | 2021 | 85 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 82 | 0.080 |
Why?
|
| Anaerobic Threshold | 1 | 2009 | 19 | 0.080 |
Why?
|
| Body Composition | 4 | 2013 | 265 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2009 | 52 | 0.070 |
Why?
|
| Physical Exertion | 1 | 2008 | 104 | 0.070 |
Why?
|
| Mitochondria | 1 | 2011 | 366 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2011 | 513 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 633 | 0.070 |
Why?
|
| Citrate (si)-Synthase | 3 | 2013 | 23 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 330 | 0.060 |
Why?
|
| Adaptation, Physiological | 3 | 2013 | 169 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2020 | 355 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 1573 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 4655 | 0.050 |
Why?
|
| Diet, Reducing | 1 | 2021 | 10 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2021 | 20 | 0.050 |
Why?
|
| Palmitates | 2 | 2013 | 9 | 0.050 |
Why?
|
| Overweight | 2 | 2013 | 111 | 0.050 |
Why?
|
| Fasting | 1 | 2021 | 82 | 0.040 |
Why?
|
| Systems Biology | 1 | 2021 | 22 | 0.040 |
Why?
|
| Developing Countries | 1 | 2021 | 50 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 109 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2021 | 210 | 0.040 |
Why?
|
| Biotransformation | 1 | 2020 | 9 | 0.040 |
Why?
|
| Urinalysis | 1 | 2020 | 11 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 2010 | 70 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 71 | 0.040 |
Why?
|
| Software | 1 | 2021 | 125 | 0.040 |
Why?
|
| Species Specificity | 1 | 2020 | 192 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 134 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 131 | 0.040 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 2 | 2010 | 3 | 0.040 |
Why?
|
| Azo Compounds | 2 | 2010 | 5 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2010 | 86 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2018 | 72 | 0.030 |
Why?
|
| Birth Weight | 1 | 2018 | 63 | 0.030 |
Why?
|
| Weight Gain | 1 | 2018 | 75 | 0.030 |
Why?
|
| Phenotype | 2 | 2010 | 679 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 131 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2015 | 7 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 2013 | 11 | 0.030 |
Why?
|
| Growth and Development | 1 | 2013 | 7 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2013 | 31 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2013 | 45 | 0.030 |
Why?
|
| Organ Size | 1 | 2013 | 86 | 0.030 |
Why?
|
| Cell Separation | 1 | 2013 | 55 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2013 | 26 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2013 | 62 | 0.030 |
Why?
|
| Arterioles | 1 | 2012 | 61 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 95 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2013 | 99 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 192 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 144 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 78 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 180 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 451 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 302 | 0.020 |
Why?
|
| Estradiol | 1 | 2013 | 175 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2013 | 84 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 252 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 102 | 0.020 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2011 | 2 | 0.020 |
Why?
|
| Diglycerides | 1 | 2011 | 10 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 248 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 21 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 194 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 120 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 694 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 94 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2011 | 107 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 60 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2011 | 78 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 100 | 0.020 |
Why?
|
| PPAR delta | 1 | 2010 | 3 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2010 | 34 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2010 | 14 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2010 | 40 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 82 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2010 | 29 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 245 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 43 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 151 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 69 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 76 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 200 | 0.020 |
Why?
|
| Peroxisomes | 1 | 2009 | 3 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 43 | 0.020 |
Why?
|
| Antioxidants | 1 | 2011 | 225 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2009 | 47 | 0.020 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2008 | 10 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2008 | 70 | 0.020 |
Why?
|
| Time | 1 | 2008 | 16 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2008 | 174 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 311 | 0.020 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2008 | 4 | 0.020 |
Why?
|
| Fatty Acid Synthases | 1 | 2008 | 7 | 0.020 |
Why?
|
| Glycogen | 1 | 2008 | 23 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2008 | 35 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 463 | 0.020 |
Why?
|
| Apoptosis | 1 | 2009 | 774 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1462 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 976 | 0.010 |
Why?
|